发布求助
文献互助 智能选刊 最新文献

TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD最新文献

筛选
英文 中文
Safety, Tolerability and Pharmacokinetics/Pharmacodynamic Assessment of an Oral, Selective Prolyl-tRNA Synthetase Inhibitor, DWN12088, for the Treatment of Idiopathic Pulmonary Fibrosis in Healthy Subjects 口服选择性脯氨酸- trna合成酶抑制剂DWN12088治疗特发性肺纤维化的安全性、耐受性和药代动力学/药效学评估
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897
M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park
{"title":"Safety, Tolerability and Pharmacokinetics/Pharmacodynamic Assessment of an Oral, Selective Prolyl-tRNA Synthetase Inhibitor, DWN12088, for the Treatment of Idiopathic Pulmonary Fibrosis in Healthy Subjects","authors":"M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122686061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Accuracy of the GAP Score in IPF Patients Treated with Antifibrotic Therapy 接受抗纤维化治疗的IPF患者GAP评分的准确性
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1900
J. Pastre, S. Valery, A. Brown, O. Shlobin, K. Ahmad, V. Khangoora, S. Aryal, C. King, S. Nathan
{"title":"Accuracy of the GAP Score in IPF Patients Treated with Antifibrotic Therapy","authors":"J. Pastre, S. Valery, A. Brown, O. Shlobin, K. Ahmad, V. Khangoora, S. Aryal, C. King, S. Nathan","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1900","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1900","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122451768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifibrotic Therapy in Fibrosing Interstitial Lung Disease: A Retrospective Analysis at a Tertiary Referral Institution 纤维化间质性肺疾病的抗纤维化治疗:一个三级转诊机构的回顾性分析
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1908
Vikas S. Koppurapu, Y. Zemkova, D. Barber, K. Shin, A. Laroia, C. Lee, K. Ussavarungsi
{"title":"Antifibrotic Therapy in Fibrosing Interstitial Lung Disease: A Retrospective Analysis at a Tertiary Referral Institution","authors":"Vikas S. Koppurapu, Y. Zemkova, D. Barber, K. Shin, A. Laroia, C. Lee, K. Ussavarungsi","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1908","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1908","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114389121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy 尼达尼布对进行性纤维化间质性肺疾病(ild)患者抗酸治疗的影响
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906
M. Kreuter, C. Glazer, H. Kitamura, D. Koschel, T. Moua, H. Müller, S. Stowasser, K. Rohr, K. Brown, on behalf of the INBUILD trial investigators
{"title":"Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy","authors":"M. Kreuter, C. Glazer, H. Kitamura, D. Koschel, T. Moua, H. Müller, S. Stowasser, K. Rohr, K. Brown, on behalf of the INBUILD trial investigators","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114270422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI) 尼达尼布对进展性纤维化间质性肺疾病(ILDs)患者的综合生理指数(CPI)影响
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1905
A. Nambiar, M. Molina-Molina, M. Padilla, J.W. Song, H. Mueller, S. Stowasser, K. Rohr, A. Wells, on behalf of the INBUILD trial investigators
{"title":"Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)","authors":"A. Nambiar, M. Molina-Molina, M. Padilla, J.W. Song, H. Mueller, S. Stowasser, K. Rohr, A. Wells, on behalf of the INBUILD trial investigators","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1905","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1905","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"412 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126691859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beneficial Effect of Polymyxin B Immobilized Fiber Cartridge Treatment in Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Prospective Multicenter Cohort Study 多粘菌素B固定化纤维筒治疗特发性肺纤维化急性加重的有益效果:一项前瞻性多中心队列研究
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1899
A. Azuma, S. Abe, H. Hayashi, T. Ogura, T. Baba, T. Oh
{"title":"Beneficial Effect of Polymyxin B Immobilized Fiber Cartridge Treatment in Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Prospective Multicenter Cohort Study","authors":"A. Azuma, S. Abe, H. Hayashi, T. Ogura, T. Baba, T. Oh","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1899","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1899","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121853211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Search for Host Factors That Predict the Therapeutic Effect of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF) 寻找预测尼达尼布治疗特发性肺纤维化(IPF)疗效的宿主因子
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1902
N. Arai, M. Matsuyama, M. Nakajima, K. Yazaki, M. Nonaka, C. Sakai, S. Matsumura, T. Numata, H. Yanai, Y. Yamamoto, Y. Akatsu, H. Iijima, H. Masuko, Y. Matsuno, Y. Morishima, T. Endo, T. Saito, N. Hizawa
{"title":"Search for Host Factors That Predict the Therapeutic Effect of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF)","authors":"N. Arai, M. Matsuyama, M. Nakajima, K. Yazaki, M. Nonaka, C. Sakai, S. Matsumura, T. Numata, H. Yanai, Y. Yamamoto, Y. Akatsu, H. Iijima, H. Masuko, Y. Matsuno, Y. Morishima, T. Endo, T. Saito, N. Hizawa","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1902","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1902","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131811888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis 硫唑嘌呤与霉酚酸酯治疗间质性肺疾病合并系统性硬化症患者的比较
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1915
J. Shell, J. Kapralik, A. Jones, M. Farooqi, K. Beattie, M. Kolb, G. Cox, C. Scallan, M. Larché, N. Khalidi, N. Hambly
{"title":"Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis","authors":"J. Shell, J. Kapralik, A. Jones, M. Farooqi, K. Beattie, M. Kolb, G. Cox, C. Scallan, M. Larché, N. Khalidi, N. Hambly","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1915","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1915","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133768474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Improvement in Patients Treated with Inhaled Treprostinil: A Post Hoc Analysis of the INCREASE Study 吸入曲前列地尼治疗患者的临床改善:一项对增加研究的事后分析
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1911
A. Waxman, V. Tapson, G. Ramani, M. Risbano, R. Bourge, M. Broderick, P. Smith, C. Deng, S. Nathan
{"title":"Clinical Improvement in Patients Treated with Inhaled Treprostinil: A Post Hoc Analysis of the INCREASE Study","authors":"A. Waxman, V. Tapson, G. Ramani, M. Risbano, R. Bourge, M. Broderick, P. Smith, C. Deng, S. Nathan","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1911","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1911","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130061686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tolerability of Mycophenolate and Azathioprine in Patients with Fibrotic Interstitial Lung Disease: A Prospective Cohort Study Using Real-World Data 霉酚酸盐和硫唑嘌呤在纤维化间质性肺病患者中的耐受性:一项使用真实世界数据的前瞻性队列研究
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1914
A. Wong, K. Donohoe, V. Marcoux, J. Fisher, K. Johannson, D. Assayag, J. Morisset, S. Shapera, N. Khalil, C. Fell, H. Manganas, G. Cox, T. To, A. Gershon, N. Hambly, A. Halayko, M. Sadatsafavi, P. Wilcox, M. Kolb, C. Ryerson
{"title":"Tolerability of Mycophenolate and Azathioprine in Patients with Fibrotic Interstitial Lung Disease: A Prospective Cohort Study Using Real-World Data","authors":"A. Wong, K. Donohoe, V. Marcoux, J. Fisher, K. Johannson, D. Assayag, J. Morisset, S. Shapera, N. Khalil, C. Fell, H. Manganas, G. Cox, T. To, A. Gershon, N. Hambly, A. Halayko, M. Sadatsafavi, P. Wilcox, M. Kolb, C. Ryerson","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1914","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1914","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"9 Pt 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126271770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信